Michael Spinner

2.2k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

Michael Spinner is a scholar working on Epidemiology, Infectious Diseases and Physiology. According to data from OpenAlex, Michael Spinner has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Physiology. Recurrent topics in Michael Spinner's work include Alzheimer's disease research and treatments (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Michael Spinner is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Michael Spinner collaborates with scholars based in United States, Italy and Egypt. Michael Spinner's co-authors include David M. Holtzman, Anne M. Fagan, Robert H. Mach, Sang‐Yoon Lee, Carmen S. Dence, Mark A. Mintun, Gina LaRossa, John C. Morris, Aarti R. Shah and Chester A. Mathis and has published in prestigious journals such as Science, Journal of Biological Chemistry and Applied and Environmental Microbiology.

In The Last Decade

Michael Spinner

24 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ ₄₂ in humans

2005 960 citations Anne M. Fagan, Mark A. Mintun et al. Annals of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Spinner United States	12	1.1k	674	354	228	216	24	1.7k
Ana Graf Switzerland	14	1.0k 0.9×	610 0.9×	318 0.9×	245 1.1×	173 0.8×	39	1.9k
Maartje I. Kester Netherlands	22	1.1k 1.0×	898 1.3×	356 1.0×	391 1.7×	123 0.6×	35	1.7k
Henrik Zetterberg Sweden	28	1.1k 1.0×	753 1.1×	640 1.8×	602 2.6×	144 0.7×	172	2.5k
Erik Stoops Belgium	24	1.5k 1.5×	1.1k 1.6×	564 1.6×	625 2.7×	191 0.9×	72	2.5k
Kina Höglund Sweden	29	1.4k 1.3×	686 1.0×	743 2.1×	606 2.7×	123 0.6×	68	2.5k
Ken Schmader United States	11	1.7k 1.6×	818 1.2×	695 2.0×	224 1.0×	123 0.6×	13	2.9k
Young Ho Park South Korea	24	411 0.4×	447 0.7×	274 0.8×	140 0.6×	228 1.1×	130	1.5k
Rawan Tarawneh United States	16	664 0.6×	386 0.6×	317 0.9×	107 0.5×	106 0.5×	29	1.5k
Yong Ji China	22	583 0.5×	237 0.4×	409 1.2×	196 0.9×	76 0.4×	81	1.5k
Jing Shi China	23	477 0.4×	241 0.4×	355 1.0×	341 1.5×	97 0.4×	134	1.7k

Countries citing papers authored by Michael Spinner

Since Specialization

Citations

This map shows the geographic impact of Michael Spinner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Spinner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Spinner more than expected).

Fields of papers citing papers by Michael Spinner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Spinner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Spinner. The network helps show where Michael Spinner may publish in the future.

Co-authorship network of co-authors of Michael Spinner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Spinner. A scholar is included among the top collaborators of Michael Spinner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Spinner. Michael Spinner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Norweg, Anna, Cheongeun Oh, Michael Spinner, et al.. (2023). Capnography-Assisted Learned, Monitored (CALM) breathing therapy for dysfunctional breathing in COPD: A bridge to pulmonary rehabilitation. Contemporary Clinical Trials. 134. 107340–107340. 2 indexed citations

Murthy, Prithvi, Michele Fascelli, Michael Spinner, et al.. (2023). Wound related complications and the anterior rectus sheath versus Gibson approach to kidney transplantation: A single center randomized controlled trial. Clinical Transplantation. 37(8). e14991–e14991. 1 indexed citations

Spinner, Michael, et al.. (2022). Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients. Transplant Infectious Disease. 24(4). e13882–e13882. 2 indexed citations

Campbell, Matthew J., et al.. (2020). Discharge prescription optimization by emergency medicine pharmacists in an academic emergency department in the United States. International Journal of Clinical Pharmacy. 43(3). 673–680. 2 indexed citations

Spinner, Michael, Simon W. Lam, Christine Koval, & Vasilios Athans. (2019). Recommended foscarnet dose is not associated with improved outcomes in cytomegalovirus salvage therapy. Journal of Clinical Virology. 120. 12–16. 2 indexed citations

Wang, Nan, et al.. (2018). A pharmacist‐driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients. Transplant Infectious Disease. 20(6). e12991–e12991. 21 indexed citations

Kovacs, Christopher, et al.. (2018). Infectious diseases consult improves vaccination adherence in kidney transplant candidates. Vaccine. 36(34). 5112–5115. 19 indexed citations

Spinner, Michael, et al.. (2018). 2484. Pre-Transplant Vaccination Adherence in Pediatric Solid Organ Transplant Patients at a Large Academic Medical Center. Open Forum Infectious Diseases. 5(suppl_1). S745–S745. 1 indexed citations

Spinner, Michael, et al.. (2018). Risk factors associated with Clostridium difficile infection in kidney transplant recipients. Transplant Infectious Disease. 20(4). e12918–e12918. 11 indexed citations

10.

Spinner, Michael, et al.. (2016). Pharmacology of testosterone replacement therapy preparations. Translational Andrology and Urology. 5(6). 834–843. 81 indexed citations

11.

Koval, Christine, Khanna, Michael Spinner, et al.. (2015). En Bloc Multivisceral and Kidney Transplantation in an HIV Patient: First Case Report. American Journal of Transplantation. 16(1). 358–363. 3 indexed citations

12.

Spinner, Michael, et al.. (2015). Single-Dose Rituximab for Recurrent Glomerulonephritis Post-Renal Transplant. American Journal of Nephrology. 41(1). 37–47. 11 indexed citations

13.

Abu‐Elmagd, Kareem, Michael Spinner, Khanna, et al.. (2015). Atypical Clinical Presentation of a Newer Generation Anti-Fungal Drug-Resistant Fusarium Infection After a Modified Multi-Visceral Transplant. Annals of Transplantation. 20. 512–518. 7 indexed citations

14.

Spinner, Michael, Georges Saab, Ed Casabar, et al.. (2010). Impact of Prophylactic Versus Preemptive Valganciclovir on Long-Term Renal Allograft Outcomes. Transplantation. 90(4). 412–418. 45 indexed citations

15.

Zanier, Elisa R., Gregory J. Zipfel, Tommaso Zoerle, et al.. (2010). Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage. Journal of Neurology Neurosurgery & Psychiatry. 82(2). 157–159. 49 indexed citations

16.

Brody, David L., Thomas J. Esparza, Sandra Magnoni, et al.. (2009). Amyloid-ss Dynamics Correlate with Neurological Status in the Injured Human Brain. 190. 1–3. 3 indexed citations

17.

Brody, David L., Sandra Magnoni, Michael Spinner, et al.. (2008). Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain. Science. 321(5893). 1221–1224. 247 indexed citations

18.

Fryer, John Denis, Ronald B. DeMattos, Lynn M. McCormick, et al.. (2005). The Low Density Lipoprotein Receptor Regulates the Level of CentralNervous System Human and Murine Apolipoprotein E but Does Not Modify AmyloidPlaque Pathology in PDAPPMice. Journal of Biological Chemistry. 280(27). 25754–25759. 111 indexed citations

19.

Fagan, Anne M., Mark A. Mintun, Robert H. Mach, et al.. (2005). Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ ₄₂ in humans. Annals of Neurology. 59(3). 512–519. 960 indexed citations breakdown →

20.

Fagan, Anne M., Jennie Taylor, Maia Parsadanian, et al.. (2004). ApoAI Deficiency Results in Marked Reductions in Plasma Cholesterol But No Alterations in Amyloid-β Pathology in a Mouse Model of Alzheimer's Disease-Like Cerebral Amyloidosis. American Journal Of Pathology. 165(4). 1413–1422. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact